[3P-0638] Development of a novel therapeutic strategy for mitochondrial disease by increasing CcO activity

〇Takemasa Nagao¹, Yasunori Shintani¹, Takaharu Hayashi², Yuya Nishida¹, Hidetaka Kioka², Seiji Takashima^1,2 (1.Dept. of Frontier Biosci., Univ. of Osaka, 2.Dept. of Med., Univ. of Osaka)

mitochondrial disease, oxidative phospholyration, cytochrome c oxidase